2 models fit QXO Inc. Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionQXO Inc. Common Stock (QXO)
Fair value (2 models)
$5.22
ACCE price target
$12.00
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 14:06 CEST; previously $4.64 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 26 Sept 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: $10.51 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
101.4% above
-50.3% to fair value
ACCE score
38
out of 100
Analysts
100% buy
19 covering
P/E
0.0x
forward 19.2x
1-year return
-42.6%
Dividend yield
0.00%
QXO Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
QXO distributes building products, and it is pursuing an aggressive acquisition strategy to consolidate a fragmented market, which explains the 70.3% revenue growth. The bull case rests on that roll-up: a larger, more diversified distribution platform could earn better purchasing terms and cross-sell into more end markets over time. Current profitability is thin, with a 24.5% gross margin, a 1.3% operating margin and negative return on equity of -4.6%, so the thesis depends on integration delivering margin expansion rather than on the business as it stands today. At a forward P/E of 19.1 on an 11.4B market cap, the stock is pricing in that earnings recovery, and the score of 38/100 suggests the screen does not yet see enough evidence to support it. The name merits a deeper look mainly to test whether acquired revenue is converting into operating income, and to establish what the forward estimates assume.